chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Injection site injury, Malaise, Pain in extremity
Clinical narrative: not  been feeling well; huge knot at injection site; under arm tenderness; painful to touch under arm; dizziness; loss of appetite; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 19Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced not been feeling well, huge knot at injection site, under arm tenderness, painful to touch under arm, dizziness and loss of appetite on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: not  been feeling well; huge knot at injection site; under arm tenderness; painful to touch under arm; dizziness; loss of appetite; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 19Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced not been feeling well, huge knot at injection site, under arm tenderness, painful to touch under arm, dizziness and loss of appetite on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, X-ray
Clinical narrative: Sore arm; This is a spontaneous report from a contactable pharmacist (patient). A 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL0142; Expiration Date: 21May2021), intramuscular on the left deltoid on 30Dec2020 as dose 1, single, for COVID-19 immunization at the workplace clinic (not a military facility). Medical history included ongoing hypothyroidism from 2014; ongoing migraines from 08Oct2020; and ongoing seasonal allergies from 2012. Concomitant medication included ibuprofen on 28Jan2020. On 30Dec2020, the patient had sore arm. The patient's x-ray on 09Feb2021 showed no abnormality. The outcome of the event was unknown. The reporter's assessment on the causal relationship between the suspect vaccine and the event was related.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chills, Hyperhidrosis, Illness, Nausea
Clinical narrative: Has been on and off sick; She is very sick; Threw up all through the night; Sweating; Chills; Her symptoms seems to be little bit nerve-racking; Nausea; This is a spontaneous report from a contactable consumer (husband) or other non hcp. A 61-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), dose 1 via an unspecified route of administration on an unspecified date (Wednesday) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included foot operation (She had surgery in her leg, major surgery in November), pain, bone disorder (lot of vitamins like Calcium and Magnesium and things like that to keep her bone strong). Concomitant medications included calcium (CALCIUM) and magnesium (MAGNESIUM). The patient experienced has been on and off sick; she is very sick, threw up all through the night, sweating, chills, her symptoms seems to be little bit nerve-racking and nausea on an unspecified date. The patient underwent lab tests and procedures which included blood test: unknown results on an unknown date. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Nerve injury, Vomiting
Clinical narrative: Has been on and off sick; She is very sick; Threw up all through the night; Sweating; Chills; Her symptoms seems to be little bit nerve-racking; Nausea; This is a spontaneous report from a contactable consumer (husband) or other non hcp. A 61-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), dose 1 via an unspecified route of administration on an unspecified date (Wednesday) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included foot operation (She had surgery in her leg, major surgery in November), pain, bone disorder (lot of vitamins like Calcium and Magnesium and things like that to keep her bone strong). Concomitant medications included calcium (CALCIUM) and magnesium (MAGNESIUM). The patient experienced has been on and off sick; she is very sick, threw up all through the night, sweating, chills, her symptoms seems to be little bit nerve-racking and nausea on an unspecified date. The patient underwent lab tests and procedures which included blood test: unknown results on an unknown date. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Limb injury, Poor quality sleep
Clinical narrative: he woke up today with a headache; he did not sleep well due to pain from a stubbed toe; he did not sleep well due to pain from a stubbed toe; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 29-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER2613), via intramuscular, administered in Arm Right on 23Mar2021 (at the age of 29-year-old) as dose 1, single for covid-19 immunisation. Medical history included none. There were no concomitant medications. On 23Mar2021, the patient experienced he did not sleep well due to pain from a stubbed toe. On 24Mar2021, patient experienced he woke up today with a headache. The outcome of the event he did not sleep well due to pain from a stubbed toe was unknown and outcome of the event he woke up today with a headache was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Limb injury
Clinical narrative: hurt her leg; This is a spontaneous report from a Pfizer-sponsored program COVAX Support. A contactable (Age: 79; unit: unknown) female consumer reported for herself that:  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 24Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported.  Patient had first dose on 24Feb2021 and scheduled to get second dose last 17March2021. However, she hurt her leg that's why was not able to attend the second dose. Medical Information: Were any unaddressed medical questions referred or forwarded to Medical Information: No. The clinical outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Heart rate increased, Pain, Vaccination site pain
Clinical narrative: Heart rate accelerated; Chest began to hurt; It feels like intense pressure in my chest. As if someone is sitting in it.; Along with body aches; Immediately the site of injection was burning.; This is a spontaneous report from a contactable consumer. This 51-years-old non pregnant female consumer (patient) reported that she received bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration, administered in arm left on 25Mar2021 11:00 (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. Age at vaccination was 51 years. The patient medical history and concomitant medications were not reported. On 25Mar2021 11:00 the patient experienced immediately the site of injection was burning, heart rate accelerated, chest began to hurt, it feels like intense pressure in my chest as if someone is sitting in it, along with body aches. Patient reported immediately the site of injection was burning. After 5 minutes her heart rate accelerated, and her chest began to hurt. It feels like intense pressure in her chest. As if someone is sitting in it. It has been almost 5 hours and she is still feeling intense chest pressure along with body aches. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Several itchy red dots on the lower right arm (left arm was injected). Dots the size of the tip of a ball point. Lower right arm feels like after a light sun burn.; Lower right arm feels like after a light sun burn; This is a spontaneous report from a contactable consumer (patient). A 45-years-old male patient received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: ER8727, patient was 45-year-old at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 26Mar2021 at 12:45 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history reported as none. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, no other medications received within 2 weeks of vaccination, prior to vaccination, the patient was not diagnosed with COVID-19, since the vaccination, the patient was not tested for COVID-19. No allergies to medications, food, or other products. On 26Mar2021at 21:30, the patient experienced several itchy red dots on the lower right arm (left arm was injected). dots the size of the tip of a ball point. lower right arm feels like after a light sun burn, lower right arm feels like after a light sun burn. No treatment was received for events. The outcomes of events were not recovered.   Follow-up (14MAY2021): Follow-up attempts completed. No further information expected.
Age: 48.0
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chest pain, Chills, Cough, Dizziness
Clinical narrative: shortness of breath/Difficult breathing; chest pain; stomach pain; 30 minutes after injection dizzy; chills; body aches; nausea; severe headache; vomiting; sweats; fever; slight cough/severe cough with the previous symptoms; This is a spontaneous report from a contactable consumer (patient). A 48-year-old patient of an unspecified gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: ER3730) via an unspecified route of administration, administered in Arm Left on 23Mar2021 17:30(age at vaccination 48-years-old) as dose 1, single for covid-19 immunisation and administered Facility was Pharmacy or Drug Store. Medical history included chronic obstructive pulmonary disease, hypertension, anaemia, fibromyalgia, depression, anxiety, asthma. Concomitant medication(s) included fluoxetine hydrochloride (PROZAC); trazodone (MANIUFACTURER UNKNOWN); vitamin d3 (MANIUFACTURER UNKNOWN); esomeprazole magnesium (NEXIUM), salbutamol sulphate (ALBUTEROL) received within 2 weeks of vaccination. The patient past drug history included Bactrim, cipro (ciprofloxacin) and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. The patient did not receive any other medication within 2 weeks of covid vaccination. The patient did not diagnose with covid-19 prior to the vaccination. The patient did not test for covid-19 since the vaccination. On 23Mar2021 18:00(30 minutes after injection) the patient experienced dizzy, chills, body aches, severe headache, nausea, vomiting, sweats, fever, slight cough/severe cough with the previous symptoms. On 26Mar2021 the patient had shortness of breath/difficult breathing, chest pain, stomach pain. The patient did not receive any treatment for the events. The outcome of the events was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Hyperhidrosis, Nausea, Pain
Clinical narrative: shortness of breath/Difficult breathing; chest pain; stomach pain; 30 minutes after injection dizzy; chills; body aches; nausea; severe headache; vomiting; sweats; fever; slight cough/severe cough with the previous symptoms; This is a spontaneous report from a contactable consumer (patient). A 48-year-old patient of an unspecified gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: ER3730) via an unspecified route of administration, administered in Arm Left on 23Mar2021 17:30(age at vaccination 48-years-old) as dose 1, single for covid-19 immunisation and administered Facility was Pharmacy or Drug Store. Medical history included chronic obstructive pulmonary disease, hypertension, anaemia, fibromyalgia, depression, anxiety, asthma. Concomitant medication(s) included fluoxetine hydrochloride (PROZAC); trazodone (MANIUFACTURER UNKNOWN); vitamin d3 (MANIUFACTURER UNKNOWN); esomeprazole magnesium (NEXIUM), salbutamol sulphate (ALBUTEROL) received within 2 weeks of vaccination. The patient past drug history included Bactrim, cipro (ciprofloxacin) and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. The patient did not receive any other medication within 2 weeks of covid vaccination. The patient did not diagnose with covid-19 prior to the vaccination. The patient did not test for covid-19 since the vaccination. On 23Mar2021 18:00(30 minutes after injection) the patient experienced dizzy, chills, body aches, severe headache, nausea, vomiting, sweats, fever, slight cough/severe cough with the previous symptoms. On 26Mar2021 the patient had shortness of breath/difficult breathing, chest pain, stomach pain. The patient did not receive any treatment for the events. The outcome of the events was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: shortness of breath/Difficult breathing; chest pain; stomach pain; 30 minutes after injection dizzy; chills; body aches; nausea; severe headache; vomiting; sweats; fever; slight cough/severe cough with the previous symptoms; This is a spontaneous report from a contactable consumer (patient). A 48-year-old patient of an unspecified gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: ER3730) via an unspecified route of administration, administered in Arm Left on 23Mar2021 17:30(age at vaccination 48-years-old) as dose 1, single for covid-19 immunisation and administered Facility was Pharmacy or Drug Store. Medical history included chronic obstructive pulmonary disease, hypertension, anaemia, fibromyalgia, depression, anxiety, asthma. Concomitant medication(s) included fluoxetine hydrochloride (PROZAC); trazodone (MANIUFACTURER UNKNOWN); vitamin d3 (MANIUFACTURER UNKNOWN); esomeprazole magnesium (NEXIUM), salbutamol sulphate (ALBUTEROL) received within 2 weeks of vaccination. The patient past drug history included Bactrim, cipro (ciprofloxacin) and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. The patient did not receive any other medication within 2 weeks of covid vaccination. The patient did not diagnose with covid-19 prior to the vaccination. The patient did not test for covid-19 since the vaccination. On 23Mar2021 18:00(30 minutes after injection) the patient experienced dizzy, chills, body aches, severe headache, nausea, vomiting, sweats, fever, slight cough/severe cough with the previous symptoms. On 26Mar2021 the patient had shortness of breath/difficult breathing, chest pain, stomach pain. The patient did not receive any treatment for the events. The outcome of the events was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site mass, Vaccination site pain
Clinical narrative: Caller stated she received the Pfizer covid vaccine first dose on 26 March 2021, she broke out in rash all over the body this morning; Injection site tenderness; She had a knot about the size of a quarter at the injection site; This is a spontaneous report from a contactable consumer (patient). A 62-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EP6955, Expiration date: Unknown), via an unspecified route of administration, administered in Arm Left on 26Mar2021 13:40 (at the age of 62-years-old) as dose 1, single for covid-19 immunization at school. Vaccine was not administered at specific facility. Medical history included knee replacement (a few years ago) and pancreas issues (but her pancreas had not acted up in a few years) from an unknown date and unknown if ongoing. Family Medical History Relevant to adverse events was not provided. The patient's concomitant medications were not reported. No other products. No prior vaccinations (within 4 weeks). No adverse events following prior vaccinations. No additional vaccines administered on same date of the Pfizer suspect. There was no history of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). Reported she got her first Pfizer COVID-19 Vaccine on Friday, 26Mar2021, and now had a rash all over her body. She said she called her doctor, and her doctor told her to call Pfizer to see what Pfizer said about her rash. She stated she was fine after getting her COVID-19 Vaccine on Friday, 26Mar2021. She said on Saturday (27Mar2021) she had some tenderness in the injection site area. She said she had a knot about the size of a quarter at the injection site. She said this morning on 29Mar2021, she had a rash all over. She said she did not start any new products or foods to cause her rash. Caller asked why it would take so long for a rash to start if she had the COVID-19 Vaccine on Friday, 26Mar2021. The caller was advised she would be transferred to Pfizer Medical Information for further assistance with her question. Reported she was fine today (29Mar2021) and had called Pfizer to find out if she needed to go the emergency room, or if she could take Benadryl for the rash. The caller was advised that Pfizer does not give medical advice, but she would transfer to Pfizer Medical Information for further assistance. Reported she does not take any medications. Caller was given report reference number. The adverse events did not result in emergency room and physician office. No Relevant Tests. The outcome of events vaccination site pain, vaccination site mass and rash was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chest pain, Chills, Hyperventilation
Clinical narrative: left arm pain immediately after injection; shoulder, upper chest and upper back pain; shoulder, upper chest and upper back pain; shoulder, upper chest and upper back pain; hyperventilate; shivering; This is a spontaneous report from a contactable other health care professional. A 23-years-old unknown pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EP6955), via intramuscular, in the left arm on 29Mar2021 at 15:00 (at the age of 23-years-old) as dose 1, single for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history included arrhythmia, dysautonomia, small fiber neuropathy, POTS (Postural orthostatic tachycardia syndrome), hemiplegic migraines, Ehlers-Danlos syndrome, syncope, cardiac valve regurgitation, anemia, IBS (Irritable bowel syndrome), GERD (Gastrooesophageal reflux disease), gastritis, colitis, esophagits, mild cervical disc disease all from an unknown date and unknown if ongoing. Known allergies were no. Allergies to medications, food, or other products were no. Concomitant medications included gabapentin, flecainide, metoprolol, omeprazole, dicycloverine hydrochloride (BENTYL), midodrine, vitamin D3, simeticone (PHAZYME AIRFREE), saccharomyces boulardii (FLORASTOR KIDS), IB guard all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination patient was diagnosed with COVID-19 was unknown and since the vaccination the patient tested for COVID-19 was unknown. The patient did receive any vaccines within four weeks prior to the vaccination was unknown. On 29Mar2021 at 15:00, the patient experienced COVID-19 vaccine given in left deltoid, she began to complain of left arm pain immediately after injection, then complained of shoulder, upper chest and upper back pain. She began to hyperventilate and was also noted to be shivering. Adverse event resulted in emergency room/department or urgent care. Patient had received treatment for event was unknown. Patient became aware of the issue with late on the evening of 29Mar. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: left arm pain immediately after injection; shoulder, upper chest and upper back pain; shoulder, upper chest and upper back pain; shoulder, upper chest and upper back pain; hyperventilate; shivering; This is a spontaneous report from a contactable other health care professional. A 23-years-old unknown pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EP6955), via intramuscular, in the left arm on 29Mar2021 at 15:00 (at the age of 23-years-old) as dose 1, single for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history included arrhythmia, dysautonomia, small fiber neuropathy, POTS (Postural orthostatic tachycardia syndrome), hemiplegic migraines, Ehlers-Danlos syndrome, syncope, cardiac valve regurgitation, anemia, IBS (Irritable bowel syndrome), GERD (Gastrooesophageal reflux disease), gastritis, colitis, esophagits, mild cervical disc disease all from an unknown date and unknown if ongoing. Known allergies were no. Allergies to medications, food, or other products were no. Concomitant medications included gabapentin, flecainide, metoprolol, omeprazole, dicycloverine hydrochloride (BENTYL), midodrine, vitamin D3, simeticone (PHAZYME AIRFREE), saccharomyces boulardii (FLORASTOR KIDS), IB guard all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination patient was diagnosed with COVID-19 was unknown and since the vaccination the patient tested for COVID-19 was unknown. The patient did receive any vaccines within four weeks prior to the vaccination was unknown. On 29Mar2021 at 15:00, the patient experienced COVID-19 vaccine given in left deltoid, she began to complain of left arm pain immediately after injection, then complained of shoulder, upper chest and upper back pain. She began to hyperventilate and was also noted to be shivering. Adverse event resulted in emergency room/department or urgent care. Patient had received treatment for event was unknown. Patient became aware of the issue with late on the evening of 29Mar. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Chromaturia, Fatigue, Headache, Hypotension, Pain in extremity
Clinical narrative: symptoms of low pressure such as shakiness and needing to lie down; symptoms of low pressure such as shakiness and needing to lie down; phlegmy cough coming from lungs; He possibly has discolored urine; arm pain/swelling; fatigue/tiredness; sore arm; slight headache; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported for himself that a 28-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported), dose 2 via an unspecified route of administration on 26Mar2021 (Age at vaccination 28 years) as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number : Not reported), via an unknown route of administration on 05Mar2021 as dose 1, single for covid-19 immunisation. On 26Mar2021, the patient experienced sore arm; slight headache; On 29Mar2021, arm pain/swelling; fatigue; tiredness; he possibly has discolored urine; On 30Mar2021, symptoms of low pressure such as shakiness and needing to lie down and phlegmy cough coming from lungs. It was reported that initially he experienced a sore arm and slight headache for the first day to day and a half. Then starting on Monday he developed arm pain/swelling, fatigue that comes and goes, symptoms of low pressure such as shakiness and needing to lie down, and a phlegmy cough coming from lungs. Its been 5 days since receiving my vaccine, how long will this last. He has been having persistent symptoms ever since he got the second dose of the covid vaccine on Friday. It has been 5 days. He has had waves of tiredness and a phlegmy cough. He has had low pressure, and he gets a little shaky without food. He possibly has discolored urine. He was asking if there was any expected time line for his symptoms to persist. Waves of tiredness: Began on Monday night. It was worse yesterday. Today he does not have much to report. He has just woken up recently. Phlegmy cough: Began last night. Today, it was not as bad as yesterday. Possibly has discolored urine: His urine was potentially discolored. He has had a small sample size over the past few days that is different than his normal urine color. Thinks that it could possibly be due to the covid vaccine but he was not totally sure. Investigation Assessment: No. The clinical outcome of event symptoms of low pressure such as shakiness and needing to lie down; phlegmy cough coming from lungs was recovering; outcome of he possibly has discolored urine was not recovered; while other events outcome were unknown.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Productive cough, Tremor
Clinical narrative: symptoms of low pressure such as shakiness and needing to lie down; symptoms of low pressure such as shakiness and needing to lie down; phlegmy cough coming from lungs; He possibly has discolored urine; arm pain/swelling; fatigue/tiredness; sore arm; slight headache; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported for himself that a 28-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported), dose 2 via an unspecified route of administration on 26Mar2021 (Age at vaccination 28 years) as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number : Not reported), via an unknown route of administration on 05Mar2021 as dose 1, single for covid-19 immunisation. On 26Mar2021, the patient experienced sore arm; slight headache; On 29Mar2021, arm pain/swelling; fatigue; tiredness; he possibly has discolored urine; On 30Mar2021, symptoms of low pressure such as shakiness and needing to lie down and phlegmy cough coming from lungs. It was reported that initially he experienced a sore arm and slight headache for the first day to day and a half. Then starting on Monday he developed arm pain/swelling, fatigue that comes and goes, symptoms of low pressure such as shakiness and needing to lie down, and a phlegmy cough coming from lungs. Its been 5 days since receiving my vaccine, how long will this last. He has been having persistent symptoms ever since he got the second dose of the covid vaccine on Friday. It has been 5 days. He has had waves of tiredness and a phlegmy cough. He has had low pressure, and he gets a little shaky without food. He possibly has discolored urine. He was asking if there was any expected time line for his symptoms to persist. Waves of tiredness: Began on Monday night. It was worse yesterday. Today he does not have much to report. He has just woken up recently. Phlegmy cough: Began last night. Today, it was not as bad as yesterday. Possibly has discolored urine: His urine was potentially discolored. He has had a small sample size over the past few days that is different than his normal urine color. Thinks that it could possibly be due to the covid vaccine but he was not totally sure. Investigation Assessment: No. The clinical outcome of event symptoms of low pressure such as shakiness and needing to lie down; phlegmy cough coming from lungs was recovering; outcome of he possibly has discolored urine was not recovered; while other events outcome were unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Illness, Nausea, Pain, Vomiting
Clinical narrative: nauseous; chest hurts; body hurts; still feeling very ill; Not been able to keep food down; This is a spontaneous report from a contactable consumer (Patient) received from a Pfizer Sponsored Programme COVAX Support. A 23-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number & expiry date note reported) via unspecified route of administration on 28Mar2021 as dose 2, single for COVID-19 Immunisation. Patient medical history and concomitant medications were not reported. Caller received the second dose of the Covid vaccine 4 days ago. There are very severe side effects she reported. On unspecified date, reported as she has not been able to keep food down. She is very nauseous. Her chest hurts, feels like it is caving in. Her body hurts and over all report everything else hurts. After the vaccine patient was still feeling very ill. Caller enquired if this is normal. She enquired what to do about the side effects and how long do they last. Lot number was not available as limited information was available over the call. The Outcome of all Events was unknown   No follow-up attempts are possible; information about lot/batch cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Hypoglycaemia, Hypotension, Pruritus
Clinical narrative: itching/itching of skin; head fog/"feeling foggy" to frontal head/funny feeling; dizziness; hypoglycemia; hypotension; generalized rash; This is a spontaneous report from a non-contactable Other HCP. A 65-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EP7534), dose 2 via an unspecified route of administration on 26Mar2021 (at the age of 65-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation and experienced head itching. On 26Mar2021, during the patient's 15-minute waiting period after the injection, the patient began to experience itching and head fog. She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, facial swelling, lip swelling and tongue swelling. She had mild reaction to her fist COVID vaccine. She had some head itching on right side. Resolved without medication. Initially with complaints of "feeling foggy" to frontal head Also feeling itching more to right side of body. Patient complains of itching of skin and dizziness (when up to bathroom) on an unspecified date in 2021. The patient received treatment included: antihistamines, water and snacks. The follow up response to treatment was good. The patient discharge: Stable to go home and follow up with PCP. On an unspecified date in 2021, she had systemic reaction (hypoglycemia, hypotension, generalized rash). The Benadryl given for itching significant improvement in this noted continues to complain of having "funny feeling" and fog. Denies headache and does not wishes of migraine headaches, but this was not similar. The patient received the treatment for the events. The outcome of the event itching/itching of skin was recovering. The outcome of the event head fog/"feeling foggy" to frontal head/funny feeling was not recovered and outcome of the other events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: itching/itching of skin; head fog/"feeling foggy" to frontal head/funny feeling; dizziness; hypoglycemia; hypotension; generalized rash; This is a spontaneous report from a non-contactable Other HCP. A 65-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EP7534), dose 2 via an unspecified route of administration on 26Mar2021 (at the age of 65-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation and experienced head itching. On 26Mar2021, during the patient's 15-minute waiting period after the injection, the patient began to experience itching and head fog. She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, facial swelling, lip swelling and tongue swelling. She had mild reaction to her fist COVID vaccine. She had some head itching on right side. Resolved without medication. Initially with complaints of "feeling foggy" to frontal head Also feeling itching more to right side of body. Patient complains of itching of skin and dizziness (when up to bathroom) on an unspecified date in 2021. The patient received treatment included: antihistamines, water and snacks. The follow up response to treatment was good. The patient discharge: Stable to go home and follow up with PCP. On an unspecified date in 2021, she had systemic reaction (hypoglycemia, hypotension, generalized rash). The Benadryl given for itching significant improvement in this noted continues to complain of having "funny feeling" and fog. Denies headache and does not wishes of migraine headaches, but this was not similar. The patient received the treatment for the events. The outcome of the event itching/itching of skin was recovering. The outcome of the event head fog/"feeling foggy" to frontal head/funny feeling was not recovered and outcome of the other events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: vaginal bleeding two days after 1st vaccine/My menstrual cycle is very regular and isn't due for 10 days; This is a spontaneous report from a contactable Nurse. A 42-year-old female patient received BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Er8737), via an unspecified route of administration, administered in left arm, (42-year-old at the time of vaccination), on 01Apr2021 at 11:45 AM as dose 1, single for covid-19 immunization. Medical history was not reported. The patient was allergic to Betadine, known allergies: PCN, Fish, Betadine, Latex. Concomitant medications included Phentermine, Desipramine, Vitamin d3, Kelp lecithin. The Patient was not a pregnant at the time of vaccination. On 03Apr2021 at 01:00 PM, the patient experienced vaginal bleeding two days after 1st vaccine and her menstrual cycle was very regular and isn't due for 10 days. The patient did not receive any treatment. The patient did not receive any other vaccines in 4 weeks. Prior vaccination, the patient had no covid, since vaccination the patient had not tested for covid. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Finger deformity, Movement disorder
Clinical narrative: I Just have couple reactions; hands are locking up; Weird finger development; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 66-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6198), via an unspecified route of administration on an unspecified date (at the age of 66-year-old) as dose 1, single for covid-19 immunisation.  The patient medical history was not reported. There were no concomitant medications. Patient experienced BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. On an unspecified date, the patient experienced i just have couple reactions; hands are locking up, weird finger development. Patient had three problem areas, three fingers that were acting bizarre on my right hand and my thumb on my left hand. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Muscle spasms
Clinical narrative: Started to have muscle spasms in the chest area; I had two quick short pains in chest after 1 hour of vaccine; This is a spontaneous report from a contactable consumer. This 47-year-old female consumer (patient) reported that:  A 47-years-old female patient (not pregnant at the time of vaccination) received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: unknown), via unspecified route, in right arm on 05Apr2021 at 15:00 (at 47-years age) as dose 1, single for covid-19 immunization. The patient medical history was not reported. Known allergies were reported as none. Other medical history as none. The concomitant drugs included clonazepam (CLONAZEPAM) taken for an unspecified indication, start and stop date were not reported. Facility type Health Clinic. The patient had not received any other vaccines within 4 weeks. The patient had experienced chest pain on 05Apr2021 at 16:00 and muscle spasms on 12Apr2021 at 08:30 am. Pt had two quick short pains in chest after 1 hour of vaccine. Had muscle spasms in the chest area on Monday, 12Apr. No other critical symptoms. Pt still get them throughout the day but less often. Not sure if from the vaccine, or muscle strain from body exercises which includes modified pushups. It was not reported whether the patient had received treatment and the patient did not receive treatment before receiving medical attention. Not had covid prior vaccination. Not tested covid post vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Pleurisy, SARS-CoV-2 test
Clinical narrative: Chest pain; pleuritis; This is a spontaneous report from a contactable consumer (patient). A 55-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0158), via an unspecified route administered in right arm on 09Apr2021 at 13:30 (at the age of 55 years) as a single dose for covid-19 immunisation. Medical history included high blood pressure, melanoma stage 2, right lung segmentectomy, and known allergies with penicillin, and latex, were from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient received other medications within 2 weeks of vaccination. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ER8727), via an unspecified route administered in right arm on 19Mar2021 at 11:30 (at the age of 55 years) as a single dose for covid-19 immunisation. On 09Apr2021 at 21:00, the patient experienced chest pain and pleuritis. Treatment was not received for the adverse event. The patient underwent lab tests and procedures which included sars-cov-2 test (Nasal Swab, PCR/NAAT): negative on 13Apr2021. The outcome of events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Pyrexia
Clinical narrative: temperature of 100 (unknown units); Fatigue; Joint pain; The initial case was missing the following minimum criteria: unspecified AE. Upon receipt of follow-up information on 30Aug2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer (patient) via the Pfizer-sponsored program.   A 73-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Batch/Lot Number: EN0150), dose 2 via an unspecified route of administration on 05Apr2021 09:30 (at the age of 73-years-old) as dose 2, single and  on 15Mar2021 (Batch/Lot Number: EN6207) as dose 1, single for covid-19 immunization. Patient had no medical history and concomitant drugs. Prior to vaccination, the patient did not receive any other vaccines. The patient experienced temperature of 100 (unknown units), fatigue  and joint pain on 2021. The outcome of the event was unknown.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: Spotting (vaginal bleeding) within 1 hour of the inoculation.; This is a spontaneous report from a contactable consumer. A 31-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, Batch/Lot Number: en3208), dose 1 via an unspecified route of administration in arm left on 18Mar2021 at 12:15 (age at the time of vaccination was 31-year-old) as single dose for COVID-19 immunization. The patient was not pregnant at time of vaccination. Medical history included asthma, seasonal allergy; all from an unknown date and unknown if ongoing. The patient previously took clindamycin and experienced drug hypersensitivity. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had not tested for COVID-19. Patient received other medications within 2 weeks was vitamin (one day). On 18Mar2021 at 13:45, the patient experienced spotting within 1 hour of the inoculation. The patient did not receive any treatment for AE. The outcome of events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Limb injury, Pain in extremity, Peripheral swelling, Thrombophlebitis
Clinical narrative: About 2 weeks after the first dose, my leg swelled up; my leg swelled up and got very sore; my leg swelled up and got very sore, painful; my leg swelled up and got very sore, painful, and red.; Doctors advised that it was likely thrombophlebitis.; This is a spontaneous report from a contactable consumer or other non hcp.    A 37-years-old female Non-Pregnant patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot Number: EL9266), dose 1 via an unspecified route of administration, administered in Arm Left on 17Feb2021 16:00 as dose 1, single for covid-19 immunisation. Medical history included hypersensitivity, asthma. Concomitant medication(s) included levocetirizine dihydrochloride (XYZAL) taken for hypersensitivity. The patient was not pregnant at the time of vaccination. The patient had known allergies for asthma, the patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was Reported that, about 2 weeks after the first dose, leg swelled up and got very sore, painful, and red. Doctors advised that it was likely thrombophlebitis and received the second dose on March 10th, and my leg got worse a few days later and visited the emergency room and was sent to a specialist who put me on blood thinners for clotting. The only significant change or occurrence in my life is that received the vaccine. The outcome of the events was unknown. Therapeutic measures were taken as a result of about 2 weeks after the first dose, my leg swelled up (peripheral swelling), my leg swelled up and got very sore (limb injury), my leg swelled up and got very sore, painful (pain in extremity), my leg swelled up and got very sore, painful, and red. (erythema), doctors advised that it was likely thrombophlebitis. (thrombophlebitis).  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Painful respiration, SARS-CoV-2 test, Tremor
Clinical narrative: shakes; severe shortness of breath / was unable to take deep breathes; a little soreness on deep breathing; chills; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, lot number and expiration date were not reported), via an unspecified route of administration, ad-ministered in Left Arm on 02Apr2021 17:45 (at the age of 40-years-old ) as dose 1, single for COVID-19 immunization. Medical history included gastrooesophageal reflux disease with no know allergies. Concomitant medication(s) included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HY-DROCHLORIDE]) and acid reflux meds both taken for an unspecified indication, start and stop date were not reported. Patient did not receive other vaccine in four weeks. No known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient tested for covid post vaccination. After 11 days of vaccination on 12Apr2021 at 13:00, experienced severe shortness of breath, was unable to take deep breathes without pain. Considered going to Emergency Room but opted to see if it would pass. Next day was better. Still a little soreness on deep breathing. never experienced anything like it before. No fever but had some chills and shakes that night. Patient did not received any treatment for adverse events. The patient underwent lab tests and procedures which included sars-cov-2 test which was negative on 13Apr2021 with nasal swab. The outcome of the events was recovered with sequelae in 2021.  Information about the Lot/batch number has been requested.